MXXVX | VITSX | MXXVX / VITSX | |
Total Expense Ratio | 1.10 | 0.03 | 3,667% |
Annual Report Gross Expense Ratio | 1.10 | 0.03 | 3,667% |
Fund Existence | 30 years | 28 years | - |
Gain YTD | 9.693 | 13.021 | 74% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 10000 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 316M | 2.02T | 0% |
Annual Yield % from dividends | 0.00 | 1.14 | - |
Returns for 1 year | 8.41 | 13.81 | 61% |
Returns for 3 years | 51.22 | 76.06 | 67% |
Returns for 5 years | 19.07 | 84.90 | 22% |
Returns for 10 years | 38.04 | 225.83 | 17% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
OIEPX | 25.51 | 0.16 | +0.63% |
JPMorgan Equity Income R3 | |||
FAMDX | 24.24 | 0.10 | +0.41% |
FAM Small Cap Institutional | |||
RCGHX | 15.72 | 0.04 | +0.26% |
Virtus KAR Health Sciences C | |||
SMVFX | 12.02 | 0.01 | +0.08% |
Virtus Ceredex Mid-Cap Value Equity C | |||
BGETX | 14.99 | N/A | +0.03% |
Baillie Gifford International Growth 2 |